BHF-177

BHF-177
Systematic (IUPAC) name
	N-[(1R,2R,4S)-bicyclo[2.2.1]hept-2-yl]-2-methyl-5-[4-(trifluoromethyl)phenyl]-4-pyrimidinamine
Identifiers
CAS Number	917896-43-6
IUPHAR/BPS	5503
ChemSpider	26286940
Chemical data
Formula	C19H20F3N3
Molecular mass	347.377 g/mol
	SMILES C4CC2CC4CC2Nc1nc(C)ncc1-c3ccc(C(F)(F)F)cc3 ;
	InChI InChI=1S/C19H20F3N3/c1-11-23-10-16(13-4-6-15(7-5-13)19(20,21)22)18(24-11)25-17-9-12-2-3-14(17)8-12/h4-7,10,12,14,17H,2-3,8-9H2,1H3,(H,23,24,25)/t12-,14+,17+/m0/s1 ; Key:ADHZHPOKTRHZGT-DXCKQFNASA-N ;
(verify)

BHF-177 is a compound used in scientific research which acts as a positive allosteric modulator at the GABA_B receptor.^[1] It was shown to reduce self-administration of nicotine in animal studies.^[2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.